Jennifer Son, MD
Surgical Oncology · Olney, MDNPI 1619395290
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Axogen at 41.2% of the total. 2025 is the largest year on record at $2,774, more than ten times the $14 reported in 2021.
Across 19 payments — averaging $202.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$2K
- Integra Lifesciences Corporation$900
- Myriad Genetic Laboratories, Inc.$529
- Endomagnetics Ltd$506
- Hologic Sales And Service, LLC$227
- Dilon Technologies, Inc.$45
- plus $58 from 3 others
What the payments were for
- Consulting fees$1,32534%
- Travel & lodging$1,00726%
- Food & beverage$1,51939%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 6 | $1,585 |
| Integra Lifesciences Corporation | 1 | $900 |
| Myriad Genetic Laboratories, Inc. | 3 | $529 |
| Endomagnetics Ltd | 3 | $506 |
| Hologic Sales And Service, LLC | 1 | $227 |
| Dilon Technologies, Inc. | 2 | $45 |
| Leica Microsystems Inc. | 1 | $28 |
| Sanara Medtech Inc. | 1 | $16 |
| TELA Bio, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXOGUARD$2,846
- INTEGRA$1,800
- AXOGUARD HA+ NERVE PROTECTOR$1,423
- AxoGuard Nerve Cap$1,423
- Magseed$733
- Magtrace$733
- myRisk$425
- SENTIMAG$227
How this compares
$3,851 in reported general payments places this provider in the 85th percentile of 40 surgical oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Olney
- Kerri LopezBaltimore$16K
- Rebecca BrownBaltimore$13K
- Vinay GuptaRosedale$12K
- Richard MackeyTowson$5K
- Arun MavanurBaltimore$4K
- Kurtis CampbellAnnapolis$3K
- Armando SardiBaltimore$2K
- Lisa JacobsBaltimore$2K
- Daria AbolghasemiBaltimore$2K
- Meghan MilburnAnnapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.